We serve Chemical Name:p-Propylacetophenone CAS:2932-65-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:p-Propylacetophenone
CAS.NO:2932-65-2
Synonyms:4-propylacetophenone;4′-Propylacetophenone;EINECS 220-903-5;p-Propylacetophenone;4-n-Propylacetophenone;4-Propyl-1-acetyl-benzol;1-(4-Propylphenyl)Ethan-1-One;1-(4-Propylphenyl)ethanone;1-acetyl-4-propylbenzene;MFCD00041359;Ethanone, 1-(4-propylphenyl)-;4-n-propyl acetophenone
Molecular Formula:C11H14O
Molecular Weight:162.228
HS Code:2914399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:257.5±19.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.504
PSA:17.07000
Exact Mass:162.104462
LogP:3.19
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-propylacetophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-n-propyl acetophenone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-propylacetophenone Use and application,4-n-propyl acetophenone technical grade,usp/ep/jp grade.
Related News: The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday. p-Propylacetophenone manufacturer The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday. p-Propylacetophenone supplier The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. p-Propylacetophenone vendor As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. p-Propylacetophenone factory The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.
